Clinical Trials Browser

Phase 2 × Hemangiosarcoma × sintilimab × Clear all

NCT05026736 2025-08-17

Sintilimab for the Treatment of Locally Advanced, Metastatic, or Recurrent Angiosarcoma, the SiARa Cancer Study

Phase 2 Terminated

Hemangiosarcoma